Acute infections caused by the murine malarial parasite Plasmodium chabaudi adami are resolved by antibody-independent mechanisms of immunity. The fact that athymic nude mice developed high-grade unrelenting malaria and died when infected with this parasite suggested a significant role for T lymphocytes. Using adoptive transfer techniques, we demonstrated that spleen cells from either nonimmune or immune donor BALB/c mice eventually suppressed P. chabaudi adami infections in histocompatible recipient nude mice in a dose-dependent manner. Infections in recipients of "immune" spleen cells were less severe, demonstrating a depressed peak parasitemia and a shortened duration of patent infection, than was observed in recipients of normal spleen cells. Also, when sufficient numbers of immune spleen cells were transferred, the second wave of parasitemia (characteristic of this infection in nonimmune mice) failed to occur. T lymphocytes mediated protection in recipient mice, since T-cell-enriched, but not B-cell-enriched, spleen cell fractions suppressed P. chabaudi adami infections in nude mice. Protection was best achieved with T cells that bore the L3T4 phenotype. Patent parasitemias developed in all recipient mice, suggesting that the grafted cells did not limit parasite growth directly but achieved this end by activating other as yet unidentified inhibiting cell systems.
Acquired immunity to clinical malaria requires the activation of immune mechanisms sufficient to limit or inhibit the growth of asexual blood-stage plasmodia (9, 10) . While the exact nature of the underlying mechanisms remains to be determined, many researchers agree that antibodies play a major role. This opinion stems from the observation that protection against certain malarial species has been achieved by the passive transfer of hyperimmune serum (5, 11, 13) as well as by T-dependent isotypes of polyclonal (33) or monoclonal antibodies specific for merozoite antigens (19, 26) . Also, B-cell-deficient hosts often die when infected with ordinarily avirulent parasites (28, 30, 35, 36) . Even so, no single measurement of antibody activity has correlated unfailingly with resistance, and several reports show that immunity to human as well as to experimental malaria can be achieved by nonantibody mechanism(s) (14, 23, 28) . The injection of agents to induce oxidant stress suppressed parasitemias in infected mice (1, 3, 7, 8, 27) . Moreover, plasmodia were killed or inhibited by several cytokines such as tumor necrosis factor (17, 31, 32) and crisis-forming factor (23, 24) . Together, these findings suggest a possible role for cell-mediated immunity in malaria. For the most part, this possibility has stimulated little interest, as most current efforts to develop malaria vaccines continue to focus on protective antibody responses induced by parasite antigens.
Previously, we described a novel murine malaria model in which the resolution of acute infection was achieved by antibody-independent means requiring an intact T lymphocyte system (14) . Thus, B-cell-deficient as well as immunologically intact mice resolved acute Plasmodium chabaudi adami infections with similar kinetics, whereas athymic nude mice developed high-grade chronic malaria and eventually died. The expression of this immunity was dependent upon the presence of an architecturally intact spleen (15) As shown in Fig. 1A , control nude mice which had not received spleen cells developed acute malarial infections characterized by rapidly ascending parasitemias, which reached an initial peak value of approximately 30%. Subsequently, parasitemias increased gradually, and the animals displayed high-grade malarial infections until they died. Recipients of normal spleen cells, regardless of dose, developed ascending parasitemia curves that had slopes similar to those of nongrafted control mice (Fig. 1A) . However, in marked contrast to control mice, recipients of normal spleen cells subsequently suppressed their infections in a dosedependent fashion; i.e., the duration of infection was inversely proportional to the number of spleen cells injected (Fig. 1A) , with a minimum of 106 spleen cells necessary for uniform protection. Two of four recipients of 105 normal spleen cells eventually resolved their acute infections on days 45 and 63, respectively. Although a second wave of parasitemia was typically seen in all mice after the resolution of their acute malaria, the time when it occurred in individual hosts showed considerable variation (data not shown).
Spleen cells from immunized nul+ mice also transferred immunity to nulnu mice. Once again, grafted mice developed rapidly ascending parasitemias with slopes resembling those seen in control mice. Parasitemias were then suppressed in a dose-dependent manner similar to that observed in recipients of nonimmune spleen cells (Fig. 1B) . However, the duration of acute malaria in recipients of immune spleen cells was shortened in comparison with that of recipients of nonimmune spleen cells. This was especially evident in the recipients of 107 spleen cells; resolution of acute disease occurred 2 weeks earlier in these mice than it did in recipients of nonimmune spleen cells. Also, it should be noted that a second wave of parasitemia was not seen in these mice, but did occur in two of three mice that had received 106 immune spleen cells. What appear to be second and third peaks of parasitemia displayed by recipients of 106 immune spleen cells in Fig. 1B (Fig. 2A) . They did so within 36 days and thus resembled animals receiving a similar dose of unselected normal spleen cells (Fig. 1A) Passive transfer of hyperimmune serum. To determine whether the sera of reconstituted nude mice could protect nonimmune mice against infection with P. chabaudi adami, naive BALB/c nul+ mice were treated intravenously with 0.5 ml of hyperimmune serum prepared as described above. On the same day, these mice, as well as untreated control BALB/c nul+ mice, were infected intravenously with 103 P. chabaudi adami-parasitized erythrocytes. Recipients of hyperimmune serum developed acute malaria with infection kinetics identical to that observed in untreated control mice (Fig. 4) . DISCUSSION Previous attempts to study cell-mediated immunity in malaria have been complicated by the use of model systems in which antibodies are known to play an essential role in resolving acute infection. For example, the passive administration of hyperimmune serum or monoclonal antibodies protected mice against acute infection with P. yoelii (20) , and B-cell-deficient mice died when infected with the 17X strain of this parasite (29, 36) . Thus, whereas Jayawardena et al. (21) reported that T cells bearing the Lyt-1+2-phenotype mediated resistance to P. yoelii, a finding recently confirmed by Brinkmann et al. (4) , it is quite possible that they were measuring the helper role of T lymphocytes in this antibodydependent model system.
Preliminary to elucidating the mechanisms that mediate immunity to P. chabaudi adami and identifying the plasmodial antigens involved, we used adoptive transfer procedures to identify the lymphoid cells that participate in antibody-independent immunity to the parasite. Initial studies showed that spleen cells from both immune and nonimmune donor mice were capable of protecting recipient nude mice from otherwise lethal P. chabaudi adami infections. In no instance did the adoptive transfer of spleen cells, regardless of source, suppress the ascending parasitemia which occurred in the early stage mission. When nude mice that were immune to P. chabaudi were challenged with a heterologous murine malarial parasite, P. yoelii 17X, they developed significant parasitemias; and in fact five of nine animals reconstituted with less than 107 spleen cells died (data not shown), suggesting that immunity to P. chabaudi adami possessed T-cell-mediated specificity.
When T cells were compared with B cells for their ability to adoptively transfer protection to nude mice, T cells from immune or nonimmune donors protected recipient mice from otherwise lethal P. chabaudi adami infections. B-cellenriched lymphocyte fractions, even when obtained from immune mice, failed to suppress P. chabaudi adami infections, which eventually killed the recipient mice. These results contrast with those of other researchers who have studied the P. yoelii model infection and have observed that the transfer of immune B cells protected recipients against challenge infection with this parasite (21, 26) . Immunity to P. chabaudi adami was best achieved with T cells bearing the L3T4 marker indicative of the T helper/inducer subset (12 inability to totally delete L3T4 cells from the Lyt-2+ enriched fraction. Hyperimmune serum prepared by challenging T-cellreconstituted nude mice with P. chabaudi adami on three subsequent occasions failed to alter the kinetics of P. chabaudi adami infections when passively transferred to immunologically intact mice prior to challenge. These findings demonstrate that the grafted T cells did not function as helper cells in the production of protective antibodies but probably functioned in a manner analogous to that observed in immunologically intact mice, where the passive transfer of hyperimmune serum was without effect despite the ready detection of parasite-specific antibodies by immunofluorescence and immunoprecipitation techniques (D. Russo, personal communication).
It is likely that the grafted T cells are activated by malarial antigens to secrete factors that in turn stimulate other cells or cell systems to exert an antiparasite effect (6, 22) . Obvious candidates would be the cells of the mononuclear phagocytic system, which, when activated, has been shown to produce parasite inhibitory factors such as hydrogen peroxide and superoxide anion (2) , which may damage parasites by the peroxidation of membrane lipids (1) . Another candidate would be the splenic reticular cells, which become highly VOL. 52, 1986 on October 28, 2017 by guest http://iai.asm.org/ Downloaded from activated and secretory during malaria (L. Weiss, U. Geduldig, and W. P. Weidanz, submitted for publication). Parasitized erythrocytes often can be found adhering to the surface of these cells, where they may be intimately exposed to toxic molecules.
What is unique about the present study is the finding that immunity to acute P. chabaudi adami malaria is antibody independent. The use of this model system allows the investigator to study the contribution of T cells to those cell-mediated immune responses that achieve protection exclusive of their helper role in antibody formation. Our results indicate that immunity to acute infection with P. chabaudi adami is mediated by the L3T4 subset of T lymphocytes. Future studies will focus on the identification and characterization of cell-mediated immune mechanisms which protect the host against infection with this parasite as well as on the definition of malarial antigens which activate these T cells. While immune mechanisms identified in the murine infection models may represent extremes of effector responses available in the host repertoire to resist malarial infection, the value of such models is that they serve as indicators of the range of mechanisms that may function separately or in an integrated fashion to protect humans against this disease. Thus, it is conceivable that once identified, certain of these mechanisms may provide new approaches for the prophylaxis of malaria.
